Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
Qilu-antibiotic got 5 COS certificates of sterile APIs2009-12-29
Anhui invested 1.3 bn in grass-roots medical system in 20092009-12-28
Astellas lanuches Vesicare in China for OAB2009-12-25
MSD expects better China sales2009-12-25
Boehringer Ingelheim launched Micardis Plus in China2009-12-24
Gaoke's 10000 ton Vitamin C project into environmental assessment2009-12-23
Zhejiang Garden signed supply agreement of Vitamin D3 with Adisseo2009-12-22
DSM launches PureActives Cefalexin in China2009-12-21
Kunming Pharm obtained WHO GMP certification2009-12-21
Guangji's Vitamin B2 expansion project into production2009-12-21
Xiwang exports Crystalline Fructose to EU2009-12-21
NCPC to acquires whole interest of Create Pharma2009-12-18
Haijianuo finished the construction of Vitamin H project2009-12-16
Xinquan starts the project of Ceftriaxone and cephalosporin intermediates2009-12-16
Brother Enterprises finished the technology reformation of Vitamin K32009-12-16
Zanamivir listed into drug catalogue of medical insurance in Jiangxi2009-12-15
Takeda and Pfizer to co-promote Actos (pioglitazone HCl) in China2009-12-15
Lilly aims to increase its pharmaceutical presence in China2009-12-15
Jianghai Pharm newly built two API facilities2009-12-14
Guangji's 5000 ton vitamin B2 project totally finished2009-12-11
Zhejiang Garden to found 25-Dihydroxy vitamin D3 project2009-12-11
Novartis Jiangsu API base put into operation2009-12-11
Phase 3 trial of Stimuvax in Asian patients with NSCLC started2009-12-11
Export volume of Taurine expected to 12000 ton in China2009-12-10
SFDA strengthens the management of ephedrine proudct2009-12-10
Baiyunshan and DSM signed Cefalexin API supply agreement2009-12-09
Seretide Evohaler's drug administrative protection expired2009-12-08
Aerius's drug administrative protection expired2009-12-08
Vitamin C output capacity of Shandong Luwei reached 30000ton2009-12-08
Chinese hospital market scale is nearly 300 billion yuan2009-12-07
Tiger Biotech to expand vitamin C capacity2009-12-04
Weisheng's vitamin C granules passed Sweden examination2009-12-04
共4532个 页次:118/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463